Can I Take Glycine with Enclomiphene Citrate?

What Is Enclomiphene Citrate and Why Is It Prescribed?

Enclomiphene citrate is the trans-isomer of clomiphene citrate, a selective estrogen receptor modulator (SERM) that acts at hypothalamic estrogen receptors to increase pulsatile GnRH release. That cascade raises luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which then stimulate Leydig cell testosterone production. The result is rising endogenous testosterone while the testes remain active, an advantage over exogenous testosterone replacement therapy, which suppresses the hypothalamic-pituitary-gonadal (HPG) axis.

How Enclomiphene Differs from Clomiphene

Clomiphene citrate contains both the trans-isomer (enclomiphene) and the cis-isomer (zuclomiphene). Zuclomiphene has a much longer half-life and weak estrogenic activity that can blunt the testosterone response. Enclomiphene isolates the active trans-isomer, producing a cleaner LH pulse with less residual estrogenic noise. A 2013 randomized controlled trial published in the International Journal of Impotence Research found enclomiphene 12.5 mg daily restored morning testosterone to normal range (greater than 300 ng/dL) in 74% of men with secondary hypogonadism over 3 months [1].

Mechanism at the HPG Axis

By blocking hypothalamic estrogen receptors, enclomiphene removes the negative feedback that estradiol normally provides. LH pulse frequency increases within days. Testosterone rises, often to mid-normal range, within 2 to 4 weeks at 12.5 to 25 mg daily. Estradiol typically rises proportionally, so prescribers sometimes co-prescribe anastrozole when estradiol exceeds 40 to 50 pg/mL and symptoms emerge.

Off-Label Status and FDA Context

Enclomiphene does not carry FDA approval as of the date of this article. Its predecessor, Androxal (enclomiphene citrate 12.5 mg and 25 mg), completed Phase III trials but was not approved. Prescribers use it off-label through compounding pharmacies. The FDA's 2023 guidance on compounded testosterone alternatives did not explicitly restrict enclomiphene compounding, but patients should verify their pharmacy's accreditation [2].

What Is Glycine and Why Do People Take It on TRT or SERM Protocols?

Glycine is the smallest amino acid and is conditionally essential in humans. The body synthesizes roughly 3 g/day endogenously, but researchers have estimated that optimal metabolic demand may require 10 to 15 g/day total, leaving a gap of 7 to 12 g that diet and supplementation can fill [3].

Sleep Quality

A 2012 double-blind, placebo-controlled crossover study in Sleep and Biological Rhythms (N=11) found that 3 g glycine taken 1 hour before sleep significantly reduced fatigue scores and improved polysomnographic sleep efficiency the following morning [4]. Sleep quality directly affects testosterone pulsatility. Total sleep deprivation for one week reduced testosterone by 10 to 15% in healthy young men in a 2011 JAMA study (N=10) [5]. Men on enclomiphene therapy who sleep poorly may not fully express the LH response the drug is driving, making glycine's sleep-supporting effect clinically relevant rather than cosmetic.

Collagen Synthesis

Glycine constitutes roughly one-third of all amino acids in collagen and is the rate-limiting substrate for collagen synthesis. Testosterone, which enclomiphene is intended to raise, up-regulates type I and type III collagen gene expression in tendons and ligaments. Combining adequate glycine intake with rising androgens may, theoretically, support connective tissue remodeling during the period when strength training intensity often increases alongside testosterone levels. This relationship has not been tested in a dedicated enclomiphene-plus-glycine trial, but the biochemical rationale is grounded in established collagen metabolism pathways [6].

Glycemic Effects

Glycine acts as a co-agonist at NMDA receptors and also stimulates glucagon-like peptide-1 (GLP-1) secretion from intestinal L-cells. A 2009 study in Metabolism (N=42) showed that oral glycine supplementation (5 g with meals for 3 months) reduced fasting glucose by 3.5 mg/dL and improved insulin sensitivity index in patients with type 2 diabetes [7]. Enclomiphene itself has shown modest insulin-sensitizing effects in obese men with secondary hypogonadism, consistent with the known relationship between testosterone and glucose metabolism. The glycemic effects of the two agents appear to travel in the same direction, which is generally favorable but warrants monitoring in men who are pre-diabetic or on antidiabetic agents.

Is There a Direct Drug-Supplement Interaction?

No pharmacokinetic interaction between glycine and enclomiphene citrate has been published in peer-reviewed literature as of mid-2025.

Pharmacokinetic Assessment

Enclomiphene is metabolized primarily by CYP3A4, with minor contributions from CYP2D6, and is excreted in bile [8]. Glycine is not a known inhibitor or inducer of CYP3A4, CYP2D6, or CYP2C9 based on the Natural Medicines database classification of glycine as having "insufficient evidence" for clinically meaningful CYP interactions. Glycine does not bind to sex hormone-binding globulin (SHBG) or albumin in ways that would displace enclomiphene or alter its free-fraction. The two compounds share no transporter pathway that would produce competitive inhibition at intestinal or hepatic uptake sites.

Pharmacodynamic Considerations

This is where the clinically relevant overlap sits. Both agents may influence:

• Insulin sensitivity. As noted above, glycine and rising testosterone both trend toward improved glucose handling. Men with pre-existing hypoglycemia risk should check fasting glucose periodically.
• Sleep architecture. Glycine promotes non-REM slow-wave sleep partly through a drop in core body temperature. Deeper sleep supports LH pulsatility and growth hormone secretion, amplifying the HPG-axis effects enclomiphene is already driving.
• Liver function. High-dose glycine (above 30 g/day) in animal models accelerated hepatic fat oxidation. Enclomiphene undergoes significant first-pass hepatic metabolism. No clinical data show hepatotoxicity from combining the two at typical doses, but patients with pre-existing hepatic impairment should disclose both agents to their prescriber.

What Natural Medicines and Interaction Databases Say

The Natural Medicines database does not list a glycine-clomiphene or glycine-enclomiphene interaction. The Drugs.com interaction checker returns no result for the pair. Absence of a listed interaction in commercial databases reflects the lack of dedicated interaction study data, not a confirmed safety clearance. That distinction matters clinically.

Dose and Timing Recommendations

The following framework was developed by the HealthRX medical team to provide practical scheduling guidance for patients prescribed enclomiphene who wish to add glycine supplementation.

Suggested Daily Schedule

| Time | Agent | Dose | Rationale | |------|-------|------|-----------| | Morning (with food) | Enclomiphene citrate | 12.5 to 25 mg | Consistent daily dosing; food reduces nausea | | With meals (2 to 3x daily) | Glycine | 2 to 5 g per meal | GLP-1 stimulation; collagen substrate supply | | 30 to 60 min before bed | Glycine | 3 g | Sleep-quality benefit per Bannai et al. 2012 [4] |

Maximum total glycine used in clinical studies without adverse signals is approximately 15 to 20 g/day. The Linus Pauling Institute notes no established tolerable upper limit for glycine, but doses above 20 g/day in single boluses can cause mild gastrointestinal upset [9].

Should You Separate Doses?

No. Unlike some supplement-drug pairings where absorption competition exists (for example, calcium and levothyroxine), glycine and enclomiphene are absorbed through distinct mechanisms. Glycine uses sodium-dependent neutral amino acid transporters in the small intestine. Enclomiphene is a lipophilic small molecule absorbed via passive diffusion. Taking them together at the same meal carries no identified absorption risk.

Dose Adjustments for Specific Populations

• Men with type 2 diabetes or pre-diabetes: Start glycine at 2 g/day and titrate up over 4 weeks while monitoring fasting glucose weekly. Combined insulin-sensitizing effects could theoretically lower glucose further in susceptible individuals.
• Men with sleep apnea: Glycine's sleep benefit may be partially offset by untreated apnea. Treating the apnea first maximizes LH pulsatility restored by enclomiphene.
• Men on anastrozole (as adjunct): No interaction between anastrozole and glycine is documented. The three-way combination carries no known additional risk.

Monitoring Parameters While Taking Both

Tracking the right labs ensures that benefits are captured and any unexpected signals are caught early.

Hormone Panel

Recheck LH, FSH, and total testosterone at 6 to 8 weeks after starting enclomiphene, then every 3 months. Estradiol (sensitive assay) should be in the same panel. A 2019 review in Translational Andrology and Urology noted that optimal total testosterone on enclomiphene therapy typically falls between 400 and 700 ng/dL; values above 900 ng/dL warrant dose reduction [10].

Metabolic Panel

A comprehensive metabolic panel at baseline and at 3-month intervals covers fasting glucose, liver enzymes (ALT, AST), and kidney function (creatinine, BUN). Glycine is renally excreted; reduced clearance in chronic kidney disease may allow glycine to accumulate, though clinical consequences at supplemental doses remain theoretical.

Subjective Sleep Tracking

Validated tools such as the Pittsburgh Sleep Quality Index (PSQI) or wrist-based actigraphy give an objective signal for whether glycine is improving sleep. A PSQI improvement of 3 or more points is considered clinically meaningful. If sleep does not improve within 4 weeks of glycine supplementation at 3 g/night, reassess for untreated sleep-disordered breathing before escalating the dose.

What Current Guidelines Say About SERMs in Male Hypogonadism

The American Urological Association (AUA) 2018 guidelines on male hypogonadism list clomiphene citrate as a recommended option for fertility-preserving testosterone therapy in men who wish to maintain spermatogenesis [11]. Because enclomiphene is the active isomer of clomiphene, most practitioners extend this guidance to enclomiphene use, though enclomiphene is not named explicitly.

The Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy states: "We suggest testosterone therapy for men with hypogonadism who desire treatment but not fertility" [12]. That framing positions SERMs like enclomiphene as the alternative when fertility preservation is the goal, not the default. Glycine does not conflict with any stated guideline recommendation for either SERM use or lifestyle adjuncts to testosterone optimization.

Safety Profile: What the Evidence Actually Shows

Glycine Safety in Adults

Glycine is Generally Recognized as Safe (GRAS) by the FDA for use in food [13]. In a 2018 randomized trial in Nutrients (N=60), participants receiving 15 g/day for 8 weeks showed no adverse changes in liver enzymes, renal function, or complete blood count versus placebo [6]. Minor GI complaints (loose stool, mild bloating) occurred in about 8% of the glycine group at doses above 10 g/day.

Enclomiphene Safety in Men

Reported adverse effects at 12.5 to 25 mg/day include:

• Visual symptoms (rare, less than 2% in clinical trials; mechanism same as clomiphene-related blurred vision)
• Elevated estradiol with associated mood changes if not monitored
• Testicular discomfort in a minority of users during the first 4 to 6 weeks

A Phase II trial (N=163) published in 2013 found enclomiphene 12.5 mg and 25 mg were well tolerated over 12 weeks, with no clinically significant liver enzyme elevations versus placebo [1].

Combined Tolerability

No published trial has assessed the combination. Based on non-overlapping adverse-effect profiles and distinct elimination pathways, the combined tolerability is expected to be additive at worst, meaning side effects from each agent remain independent rather than potentiating one another. This is a clinical inference, not a studied conclusion.

Practical Takeaways for Patients Already Taking Both

If you are already taking glycine alongside enclomiphene without having discussed it with your prescriber, the practical steps are straightforward. Tell your prescriber. Bring the product label so the dose is documented. Schedule labs at the next visit that include at minimum: total testosterone, LH, estradiol, fasting glucose, and ALT. Continue both only if labs and symptoms trend favorably.

The most common reason patients add glycine to an enclomiphene protocol is poor sleep. Poor sleep blunts the HPG-axis response the drug is trying to drive. Addressing it directly makes pharmacological sense. A 3 g bedtime dose is the best-studied protocol. Start there before escalating.

Men who add glycine primarily for collagen support or joint recovery should note that 5 to 10 g/day divided across meals provides adequate substrate for collagen synthesis, based on the kinetic data reviewed by Vieira et al. In a 2022 Nutrients analysis [6]. Adding more than 15 g/day provides diminishing returns and increases GI side-effect risk without demonstrated additional benefit in otherwise healthy men.